Traduction de «immune » (Anglais → Français) :

It is therefore appropriate to make provision for undertakings which have received immunity from fines from a competition authority under a leniency programme to be protected from undue exposure to damages claims, bearing in mind that the decision of the competition authority finding the infringement may become final for the immunity recipient before it becomes final for other undertakings which have not received immunity, thus potentially making the immunity recipient the preferential target of litigation.

From the 1 Session of the 38 Parliament, see bills C-367, C-394 and S-35, all entitled An Act to amend the State Immunity Act and the Criminal Code (terrorist activity); from the 1 Session of the 39 Parliament, see bills C-272 and C-346, both entitled An Act to amend the State Immunity Act and the Criminal Code (terrorist activity), and Bill S-218, An Act to amend the State Immunity Act and the Criminal Code (civil remedies for vi ...[+++]ctims of terrorism); from the 2 Session of the 39 Parliament, see bills C-272 and C-346, both entitled An Act to amend the State Immunity Act and the Criminal Code (terrorist activity), and Bill S-225, An Act to amend the State Immunity Act and the Criminal Code (deterring terrorism by providing a civil right of action against the perpetrators and sponsors of terrorism); and from the 2 Session of the 40 Parliament, see bills C‑408 and S-233, both entitled An Act to amend the State Immunity Act and the Criminal Code (deterring terrorism by providing a civil right of action against perpetrators and sponsors of terrorism); and from the 3 Session of the 40 Parliament: see Bill C-408, entitled An Act to amend the State Immunity Act and the Criminal Code (deterring terrorism by providing a civil right of action against perpetrators and sponsors of terrorism).

18. The privileges, immunities, and powers to be held, enjoyed, and exercised by the Senate and by the House of Commons, and by the members thereof respectively, shall be such as are from time to time defined by Act of the Parliament of Canada, but so that any Act of the Parliament of Canada defining such privileges, immunities, and powers shall not confer any privileges, immunities, or powers exceeding those at the passing of such Act held, enjoyed, and exercised by the Commons House of Parliament of the United Kingdom of Great Britain and Ireland, and by the members thereof.

(Return tabled) Question No. 226 Hon. Mark Eyking: With regard to the Canadian International Development Agency’s spending on the delivery of vaccines and immunizations through Canada's official development assistance: (a) what are Canada’s current and future financial commitments on vaccines and immunizations from all branches, projects and programs within CIDA, including bilateral, multilateral, and geographic/partnership branch, broken down by individual commitment; (b) what specific current or future immunizations or vaccines programs or projects, broken down by recipient country and CIDA stream of funding with associated funding amounts, are related to the roll-out of the Muskoka Initiative; and (c) when has the monitoring and evalua ...[+++]tion of Canada’s immunizations and vaccines programs as promised by the Prime Minister during the 2010 Muskoka G8 taken place or when will it take place and will it be under the auspices of the United Nations Commission on Information and Accountability for Women’s and Children’s Health?

In its Decision to lift the immunity from fines, the Commission also states that : (a) the decision does no more than terminate an immunity which the TACA parties could claim by virtue of the formal notification of their agreement and re-establishes them in the legal position in which they found themselves before the notification (at which time they knew that the Commission was not prepared to grant individual exemption to inland price fixing), and (b) the withdrawal of immunity does not entail any obligation on the Commission to impose fines.

That the papers and evidence received and taken and work accomplished by the Standing Senate Committee on Legal and Constitutional Affairs during its study of Bill C-15, An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts, during the Second Session of the Fortieth Parliament, and Bill S-10, An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts, during the Third Session of the Fortieth Parliament; and that the papers and evidence received and taken by the Special Senate Committee on Anti-Terrorism, during its study of Bill S-7, An Act to deter terrorism and to amend the State ...[+++]Immunity Act during the Third Session of the Fortieth Parliament and by the Standing Senate Committee on Legal and Constitutional Affairs, during its study of Bill S-225, An Act to amend the State Immunity Act and the Criminal Code (deterring terrorism by providing a civil right of action against perpetrators and sponsors of terrorism), during the Second Session of the Thirty-Ninth Parliament, be referred to the Standing Senate Committee on Legal and Constitutional Affairs for the purposes of its study on Bill C-10, An Act to enact the Justice for Victims of Terrorism Act and to amend the State Immunity Act, the Criminal Code, the Controlled Drugs and Substances Act, the Corrections and Conditional Release Act, the Youth Criminal Justice Act, the Immigration and Refugee Protection Act and other Acts, during the current session.